As filed with the Securities and Exchange Commission on March 23, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
GoHealth, Inc.
(Exact name of registrant as specified in its charter)
DELAWARE | 85-0563805 | |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
214 West Huron St., Chicago, Illinois 60654
(Address of Principal Executive Offices) (ZIP Code)
GOHEALTH, INC. 2020 INCENTIVE AWARD PLAN
GOHEALTH, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plan)
BRIAN FARLEY, ESQ.
Chief Legal Officer and Corporate Secretary
GoHealth, Inc.
214 West Huron St.
Chicago, Illinois 60654
(Name and address of agent for service)
(312) 386-8200
(Telephone number, including area code, of agent for service)
Copies to:
IAN D. SCHUMAN, ESQ.
STELIOS G. SAFFOS, ESQ.
BRITTANY RUIZ, ESQ.
LATHAM & WATKINS LLP
1271 Avenue of the Americas
NEW YORK, New York 10020
(212) 906-1200
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act of 1934.
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed with the Securities and Exchange Commission (the Commission) for the purpose of registering an additional 6,929,407 shares of the Companys Class A Common Stock issuable under the following employee benefit plans for which registration statement of the Company on Form S-8 (File No. 333-239879) is effective: (i) the 2020 Plan, which, as a result of the operation of an automatic annual increase provision therein, added 5,774,506 shares of Common Stock, and (ii) the 2020 ESPP, which, as a result of the operation of an automatic annual increase provision therein, added 1,154,901 shares of Common Stock.
Incorporation of Documents by Reference.
Pursuant to Instruction E of Form S-8, the contents of the Registration Statements on Form S-8 filed with the Commission on July 15, 2020 (File No. 333-239879) and February 10, 2021 (File No. 333-252962) is incorporated by reference herein; except for Item 8 which is being updated by this Registration Statement.
Item 8. Exhibits.
The Exhibits listed on the accompanying Index to Exhibits are filed as part hereof, or incorporated by reference into, this Registration Statement. See Exhibit Index below.
EXHIBIT INDEX
* | Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Chicago, State of Illinois, on March 23, 2022.
GOHEALTH, INC. | ||
By | /s/ Clinton P. Jones | |
Clinton P. Jones | ||
Chief Executive Officer |
Each of the undersigned officers and directors of GoHealth, Inc. hereby constitutes and appoints Clinton P. Jones and Travis J. Matthiesen, and each of them any of whom may act without joinder of the other, the individuals true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for the person and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement and any and all amendments (including post-effective amendments) to this Registration Statement and all documents relating thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing necessary or advisable to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that such attorneys-in-fact and agents, each acting alone, or such persons substitute or substitutes, lawfully may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ Clinton P. Jones |
Chief Executive Officer and Director (Principal Executive Officer) | March 23, 2022 | ||
Clinton P. Jones | ||||
/s/ Travis J. Matthiesen |
Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | March 23, 2022 | ||
Travis J. Matthiesen | ||||
/s/ Brandon M. Cruz |
Director | March 23, 2022 | ||
Brandon M. Cruz | ||||
/s/ Joseph G. Flanagan |
Director | March 23, 2022 | ||
Joseph G. Flanagan | ||||
/s/ Helene D. Gayle |
Director | March 23, 2022 | ||
Helene D. Gayle | ||||
/s/ Jeremy W. Gelber |
Director | March 23, 2022 | ||
Jeremy W. Gelber |
/s/ Anita V. Pramoda |
Director | March 23, 2022 | ||
Anita V. Pramoda | ||||
/s/ Miriam A. Tawil |
Director | March 23, 2022 | ||
Miriam A. Tawil | ||||
/s/ Alexander E. Timm |
Director | March 23, 2022 | ||
Alexander E. Timm |
Exhibit 5.1
1271 Avenue of the Americas | ||||
New York, New York 10020-1401 | ||||
Tel: +1.212.906.1200 Fax: +1.212.751.4864 | ||||
www.lw.com
|
||||
FIRM / AFFILIATE OFFICES | ||||
Austin | Moscow | |||
Beijing | Munich | |||
Boston | New York | |||
Brussels | Orange County | |||
Century City | Paris | |||
Chicago | Riyadh | |||
March 23, 2022 | Dubai | San Diego | ||
Düsseldorf | San Francisco | |||
Frankfurt | Seoul | |||
Hamburg | Shanghai | |||
Hong Kong | Silicon Valley | |||
Houston | Singapore | |||
London | Tel Aviv | |||
Los Angeles | Tokyo | |||
Madrid | Washington, D.C. | |||
Milan |
GoHealth, Inc.
214 West Huron St.
Chicago, Illinois 60654
Re: | Registration Statement on Form S-8 with respect to 6,929,407 shares of Class A common stock, par value $0.0001 per share |
To the addressee set forth above:
We have acted as special counsel to GoHealth, Inc., a Delaware corporation (the Company), in connection with the preparation and filing by the Company on the date hereof with the Securities and Exchange Commission (the Commission) of a Registration Statement (the Registration Statement) on Form S-8 under the Securities Act of 1933, as amended (the Act), relating to the issuance of up to 6,929,407 shares of Class A common stock of the Company, par value $0.0001 per share (the Shares), which may be issued pursuant to the Companys 2020 Incentive Award Plan (the 2020 Plan) and the Companys 2020 Employee Stock Purchase Plan (the 2020 ESPP, and, together with the 2020 Plan, the Plans).. This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, other than as expressly stated herein with respect to the issuance of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the DGCL), and we express no opinion with respect to any other laws.
Subject to the foregoing and the other matters set forth herein, it is our opinion that as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company for legal consideration in excess of par value in the circumstances contemplated by the Plans, assuming in each case that the individual issuances, grants or awards under the Plans
March 23, 2022
Page 2
are duly authorized by all necessary corporate action and duly issued, granted or awarded and exercised in accordance with the requirements of law and the Plans (and the agreements duly adopted thereunder and in accordance therewith), the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and such Shares will be validly issued, fully paid and non-assessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.
This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.
Very truly yours, |
/s/ Latham & Watkins LLP |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2020 Incentive Award Plan and the 2020 Employee Stock Purchase Plan of GoHealth, Inc. of our reports dated March 16, 2022, with respect to the consolidated financial statements of GoHealth, Inc. and the effectiveness of internal control over financial reporting of GoHealth, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Chicago, Illinois
March 23, 2022
Exhibit 107
CALCULATION OF FILING FEE TABLE
FORM S-8
(Form Type)
GOHEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)
Table I: Newly Registered Securities
Plan | Security Type |
Security Class Title |
Fee |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Offering Price |
Fee Rate |
Amount of Registration Fee | ||||||||
2020 Incentive Award Plan | Equity | Class A Common Stock, par value $0.0001 per share | Rule 457(c) and 457(h) | 5,774,506(2) | $1.23(4) | $7,102,642.38 | $92.70 per million dollars | $658.42 | ||||||||
2020 Employee Stock Purchase Plan | Equity | Class A Common Stock, par value $0.0001 per share | Rule 457(c) and 457(h) | 1,154,901(3) | $1.23(4) | $1,420,528.23 | $92.70 per million dollars | $131.69 | ||||||||
Total Offering Amounts | $8,523,170.61 | $790.11 | ||||||||||||||
Total Fee Offsets | $ | |||||||||||||||
Net Fee Due | $790.11 |
(1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the Securities Act), this Registration Statement shall also cover any additional shares of Class A Common Stock, par value $0.0001 per share (Common Stock), of GoHealth, Inc. (the Company) that become issuable under the Companys 2020 Incentive Award Plan (the 2020 Plan) and the Companys 2020 Employee Stock Purchase Plan (the 2020 ESPP) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock. |
(2) | Represents 5,774,506 additional shares of the Companys Common Stock that became available for issuance on January 1, 2022 under the 2020 Plan, pursuant to the terms of the 2020 Plan. |
(3) | Represents 1,154,901 additional shares of the Companys Common Stock that became available for issuance on January 1, 2022 under the 2020 ESPP, pursuant to the terms of the 2020 ESPP. |
(4) | This estimate is made pursuant to Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee. The Proposed Maximum Offering Price Per Unit for shares available for future grant is the average of the high and low prices for the registrants Common Stock as reported on The Nasdaq Global Select Market on March 16, 2022. |